MediLexicon Logo
MediLexicon Logo
Abbreviations        Abbrev Definitions        Dictionary        ICD Codes        Equipment        Hospitals        Drugs        More..


Company: Purepac Pharmaceutical
Approval Status: Approved July 1996
Treatment for: chronic pain
Areas: Musculoskeletal; Neurology & Nervous System; Cancer & Oncology

| General Information |

General Information

Kadian, a single daily dosage sustained-release morphine product, has been approved by the FDA. Kadian provides relief for chronic moderate to severe pain (pain related to cancer), and has been demonstrated to be as effective when taken once a day as conventional morphine products taken every four hours.

< back to top

Kadian Drug Information

The Kadian drug information shown above is licensed from Thomson CenterWatch. The information provided here is for general educational purposes only and does not constitute medical or pharmaceutical advice which should be sought from qualified medical and pharmaceutical advisers.

MediLexicon International Ltd Logo

Privacy Policy   |    Disclaimer   |    Contact / Feedback

MediLexicon International Ltd
Bexhill-on-Sea, UK
MediLexicon International Ltd © 2004-2016 All rights reserved.